Clinical trial
Antiplatelet Activity of Aspirin in Infants After Aortopulmonary and Cavopulmonary Shunts
NCT01656993 is registered in ClinicalTrials.gov with University of Utah as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Antiplatelet Activity of Aspirin in Infants After Aortopulmonary and Cavopulmonary Shunts
- Lead sponsor
- University of Utah
- Phase
- Observational
- Overall status
- Completed
- Start date
- November 30, 2012
- Completion date
- December 31, 2014
- Enrollment
- 25 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
congenital heart disease